GlassScriptPhysician profile
Maira Ochoa
NPI 1003303769
$1,174.27
in general payments reported to CMS, 2019-2025
13 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $317 · 2022: $159 · 2023: $234 · 2024: $88.29 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $283.42 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $226.16 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $163.16 | 2023-2025 | |
| Biogen, INC. | $122.10 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $119.94 | 2021-2023 | Balcoltra |
| Pfizer INC. | $53.82 | 2021-2022 | |
| Becton, Dickinson and Company | $40.76 | 2023 | Bd Onclarity |
| Hologic Sales and Service, LLC | $39.96 | 2023-2025 | Aptima |
| Merck Sharp & Dohme LLC | $35.74 | 2021 | |
| Myovant Sciences INC. | $32.15 | 2022 | |
| Evofem Biosciences, INC. | $24.82 | 2022 | |
| Therapeuticsmd, INC. | $17.06 | 2021 | |
| Medtronic, INC. | $15.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maira Ochoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.